Finch Therapeutics Group Inc (FNCH)
Finch Therapeutics Group Market Cap: 3.244M for May 23, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 22, 2024 | 3.420M |
May 21, 2024 | 3.726M |
May 20, 2024 | 3.597M |
May 17, 2024 | 3.115M |
May 16, 2024 | 3.083M |
May 15, 2024 | 3.372M |
May 14, 2024 | 3.115M |
May 13, 2024 | 3.019M |
May 10, 2024 | 3.228M |
May 09, 2024 | 3.260M |
May 08, 2024 | 3.404M |
May 07, 2024 | 3.501M |
May 06, 2024 | 3.581M |
May 03, 2024 | 3.693M |
May 02, 2024 | 3.998M |
May 01, 2024 | 3.708M |
April 30, 2024 | 3.597M |
April 29, 2024 | 3.693M |
April 26, 2024 | 3.726M |
April 25, 2024 | 3.597M |
April 24, 2024 | 3.693M |
April 23, 2024 | 4.478M |
April 22, 2024 | 3.709M |
April 19, 2024 | 3.597M |
April 18, 2024 | 3.790M |
Date | Value |
---|---|
April 17, 2024 | 4.047M |
April 16, 2024 | 4.978M |
April 15, 2024 | 3.605M |
April 12, 2024 | 3.260M |
April 11, 2024 | 3.774M |
April 10, 2024 | 3.934M |
April 09, 2024 | 3.942M |
April 08, 2024 | 3.533M |
April 05, 2024 | 3.534M |
April 04, 2024 | 3.677M |
April 03, 2024 | 3.854M |
April 02, 2024 | 3.950M |
April 01, 2024 | 4.095M |
March 28, 2024 | 4.175M |
March 27, 2024 | 4.647M |
March 26, 2024 | 4.247M |
March 25, 2024 | 4.336M |
March 22, 2024 | 4.127M |
March 21, 2024 | 4.191M |
March 20, 2024 | 4.400M |
March 19, 2024 | 4.480M |
March 18, 2024 | 4.368M |
March 15, 2024 | 4.103M |
March 14, 2024 | 4.014M |
March 13, 2024 | 4.111M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
ACADIA Pharmaceuticals Inc | 2.568B |
Vanda Pharmaceuticals Inc | 286.04M |
Sage Therapeutics Inc | 680.06M |
BioSig Technologies Inc | 20.46M |
Palisade Bio Inc | 4.876M |
Market Cap Related Metrics
PS Ratio | 5.281 |
PEG Ratio | -0.0002 |
Price to Book Value | 0.1704 |
Price | 2.02 |
Earnings Yield | -502.0% |
PEGY Ratio | -0.0002 |